Ines F. Eiriz

Amadora, Portugal

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

Subsequent Treatments After Progression on Cyclin-Dependent Kinase 4/6 Inhibitors: A Review of the Evidence and a Real-World Data Perspective From Portuguese Hospitals.

Subsequent Treatments After Progression on Cyclin-Dependent Kinase 4/6 Inhibitors: A Review of the Evidence and a Real-World Data Perspective From Portuguese Hospitals.

Journal: Cureus
Published: May 17, 2026

Trastuzumab Deruxtecan in Previously Treated HER2-Low Metastatic Breast Cancer: Real-World Multicentric Study in the Portuguese Population.

Trastuzumab Deruxtecan in Previously Treated HER2-Low Metastatic Breast Cancer: Real-World Multicentric Study in the Portuguese Population.

Journal: Cancers
Published: April 27, 2025

Real-Life Experience of HER2 (Human Epidermal Growth Factor Receptor 2)-Positive Advanced Breast Cancer Patients Treated With T-DXd (Trastuzumab Deruxtecan): A Multicentric Portuguese Study.

Real-Life Experience of HER2 (Human Epidermal Growth Factor Receptor 2)-Positive Advanced Breast Cancer Patients Treated With T-DXd (Trastuzumab Deruxtecan): A Multicentric Portuguese Study.

Journal: Cureus
Published: February 26, 2025

Lung Adenocarcinoma and Peripheral Blood Eosinophilia.

Lung Adenocarcinoma and Peripheral Blood Eosinophilia.

Journal: Cureus
Published: November 23, 2024

Systemic treatment for brain metastasis in HER2- positive advanced breast cancer: what have we learned so far?

Systemic treatment for brain metastasis in HER2- positive advanced breast cancer: what have we learned so far?

Journal: Oncotarget
Published: July 07, 2023

Preclinical and clinical efficacy of trastuzumab-deruxtecan in breast cancer brain metastases: a new insight on central nervous system activity.

Preclinical and clinical efficacy of trastuzumab-deruxtecan in breast cancer brain metastases: a new insight on central nervous system activity.

Journal: Annals of translational medicine
Published: May 09, 2023

Correction: Association of Tumor-Infiltrating Lymphocytes With Survival in Stages II and III Colorectal Cancer.

Correction: Association of Tumor-Infiltrating Lymphocytes With Survival in Stages II and III Colorectal Cancer.

Journal: Cureus
Published: January 13, 2023

Association of Tumor-Infiltrating Lymphocytes With Survival in Stages II and III Colorectal Cancer.

Association of Tumor-Infiltrating Lymphocytes With Survival in Stages II and III Colorectal Cancer.

Journal: Cureus
Published: November 06, 2022

Refining Therapy in Patients with HER2-Positive Breast Cancer with Central Nervous System Metastasis.

Refining Therapy in Patients with HER2-Positive Breast Cancer with Central Nervous System Metastasis.

Journal: Breast care (Basel, Switzerland)
Published: June 04, 2022

Neutrophile-to-lymphocyte, lymphocyte-to-monocyte, and platelet-to-lymphocyte ratios as prognostic and response biomarkers for resectable locally advanced gastric cancer.

Neutrophile-to-lymphocyte, lymphocyte-to-monocyte, and platelet-to-lymphocyte ratios as prognostic and response biomarkers for resectable locally advanced gastric cancer.

Journal: World journal of gastrointestinal oncology
Published: August 02, 2021

The Reality of Critical Cancer Patients in a Polyvalent Intensive Care Unit.

The Reality of Critical Cancer Patients in a Polyvalent Intensive Care Unit.

Journal: Cureus
Published: April 02, 2021

Uterine Sarcomas: A Retrospective Analysis of a Cohort of 62 Patients.

Uterine Sarcomas: A Retrospective Analysis of a Cohort of 62 Patients.

Journal: Cureus
Published: March 22, 2021
Showing 1-12 of 14

Last Updated: 09/26/2026